Alexion Pharmaceuticals (ALXN) - 21 Year Stock Price History

Historical daily stock prices for Alexion Pharmaceuticals since 1996 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Alexion Pharmaceuticals (ALXN) as of October 17, 2017 is 143.16.

Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $31.433B $3.084B
Alexion Pharmaceuticals develops pharmaceutical products for the treatment of heart disease, and inflammation, diseases of the immune system and cancer in humans. The company's lead product candidates are genetically altered antibodies that target specific diseases which arise when the human immune system induces undesired inflammation in the human body. These candidates are designed to block components of the human immune system which cause undesired inflammation while allowing beneficial components of the immune system to remain functional.